1. In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A (H1N1) viruses;Sleeman;Antimicrob Agents Chemother.,2010
2. Fuji Film Toyama Pharmaceuticals. [Media release. Approval of antiinfluenza drug “Avigan 200 mg tablet” in Japan]. Available from: https://www.toyama-chemical.co.jp/news/detail/140324.html (Accessed on 2016 Jun 12) Japanese.
3. Favipiravir as a potential countermeasure against neglected and emerging RNA viruses;Delang;Antiviral Res.,2018
4. A review of the safety of favipiravir–a potential treatment in the COVID-19 pandemic?;Pilkington;J Virus Erad.,2020
5. Experimental treatment with favipiravir for COVID-19: an open-label control study;Cai;Engineering,2020